CHARLOTTE CUNNINGHAM-RUNDLES

Allopathic & Osteopathic Physicians|Internal Medicine|Allergy & Immunology NEW YORK, NY NPI 1619906427

General Payments — all program years on this page

$80,610.22

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 60
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $23,966.43 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Grifols USA, LLC $9,580.795
Pharming Healthcare, Inc. $8,450.005
Grifols, S.A. $3,215.641
Otsuka Pharmaceutical Development & Commercialization, Inc. $2,720.003

By program year

Program yearAmountRecords
2018 $90.522
2019 $120.212
2020 $11,147.857
2021 $10,972.408
2022 $24,093.4112
2023 $10,219.4015
2024 $23,966.4314

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1118836233 Otsuka Pharmaceutical Development & Commercialization, Inc. $1,360.00 01/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1118836235 Otsuka Pharmaceutical Development & Commercialization, Inc. $680.00 09/13/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1118836237 Otsuka Pharmaceutical Development & Commercialization, Inc. $680.00 11/15/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1124722481 Grifols, S.A. $3,215.64 11/06/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1124722483 Grifols USA, LLC $8,200.00 01/30/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1124722485 Grifols USA, LLC $473.38 01/25/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1124722487 Grifols USA, LLC $50.19 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124722489 Grifols USA, LLC $529.42 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124722491 Grifols USA, LLC $327.80 01/08/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1132145757 Pharming Healthcare, Inc. $1,200.00 02/24/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1132145763 Pharming Healthcare, Inc. $3,000.00 03/27/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1132145770 Pharming Healthcare, Inc. $1,800.00 04/30/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1132145775 Pharming Healthcare, Inc. $650.00 08/13/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1132145783 Pharming Healthcare, Inc. $1,800.00 11/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.